G

GH Research PLC
D

GHRS

12.510
USD
-1.50
(-10.71%)
مغلق
حجم التداول
13,087
الربح لكل سهم
-1
العائد الربحي
-
P/E
-16
حجم السوق
775,972,094
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: GH Research PLC

القطاع: Healthcare
الصناعة: Biotechnology
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.